Gilead Sciences, Inc. v. Lupin Ltd. et al

Track this case

Case Number:

1:22-cv-00615

Court:

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Judge:

Maryellen Noreika

Firms

Companies

Sectors & Industries:

Healthcare
- Generic
- Major

September 02, 2025
Gilead Rival Agrees Not To Sell Generic HIV Drug For Now

A Gilead Sciences Inc. competitor has agreed not to sell a generic version of Gilead's human immunodeficiency virus treatment Biktarvy until a trio of patents expire, according to a proposal by the parties to end infringement allegations.
May 10, 2022
Gilead Slaps Rivals With Patent Suit Over HIV Drug

Gilead Sciences Inc. has initiated a drug patent suit against a trio of competitors in Delaware federal court, seeking to block three generic versions of its human immunodeficiency virus treatment Biktarvy.